Tekla Capital Management LLC Edwards Lifesciences Corp Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tekla Capital Management LLC holds 189,597 shares of EW stock, worth $17.7 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

189,597

Previous 171,146 10.78%

Holding current value

$17.7 Million

Previous $14.2 Million 26.32%

% of portfolio

0.71%

Previous 0.54%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $1.5 Million - $1.74 Million	18,451 Added 10.78%	189,597 $17.9 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $17,970 - $20,451	-242 Reduced 0.14%	171,146 $14.2 Million
Q2 2022 Jul 29, 2022	SELL	$86.5 - $128.27 $501,700 - $743,966	-5,800 Reduced 3.27%	171,388 $16.3 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $1.86 Million - $2.28 Million	-17,442 Reduced 8.96%	177,188 $23 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $2.77 Million - $3.31 Million	-26,925 Reduced 12.15%	194,630 $22 Million

Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $1.44 Million - $1.8 Million	-17,200 Reduced 7.2%	221,555 $22.9 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $2.06 Million - $2.38 Million	-26,200 Reduced 9.89%	238,755 $20 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $1.88 Million - $2.39 Million	-26,200 Reduced 9.0%	264,955 $24.2 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $5.98 Million - $7.78 Million	89,009 Added 44.03%	291,155 $23.2 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $7.75 Million - $10.4 Million	134,764 Added 200.0%	202,146 $14 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $113,991 - $176,175	-2,175 Reduced 3.13%	67,382 $12.7 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $309,528 - $354,382	4,317 Added 6.62%	69,557 $16.2 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $278,759 - $341,622	-4,529 Reduced 6.49%	65,240 $14.3 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $723,003 - $835,462	12,971 Added 22.84%	69,769 $12.9 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $923,466 - $1.13 Million	-19,898 Reduced 25.94%	56,798 $8.7 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $476,239 - $604,730	10,421 Added 15.72%	76,696 $13.4 Million
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $43,698 - $55,753	1,175 Added 1.8%	66,275 $9.25 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $1.09 Million - $1.27 Million	-32,300 Reduced 33.16%	65,100 $7.34 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $3.53 Million - $3.78 Million	97,400	97,400 $10.6 Million

Others Institutions Holding EW

# of Institutions

1,375

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Edwards Lifesciences Corp Transaction History